FDA approves Biogen's Plegridy, builds on $30B MS portfolio
August 18, 2014 at 12:26 PM EDT
Drug maker Biogen Idec received approval to sell one of its newest multiple sclerosis drugs in the United States and will manufacture the drug in RTP...